Company says its test is the world’s first urine-based screening for the virus that causes 95 per cent of cervical cancer cases.
Monday 13 October 2025
scmp - 5 month ago
Hong Kong’s Phase Scientific gets US$34 million to advance test for cancer risk factor HPV

⁞
